VAREX IMAGING CORPORATION Financials Varex Imaging Corporation
Equities
VREX
US92214X1063
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.79 USD | -0.65% |
|
-1.18% | -18.10% |
Valuation
| Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,084 | 482 | 1,127 | 853.5 | 758.9 | 682 | - |
| Enterprise Value (EV) 1 | 1,449 | 836.7 | 1,127 | 853.5 | 758.9 | 682 | 682 |
| P/E ratio | 65.8 x | -8.39 x | 66.4 x | 29.3 x | 17.4 x | 21.7 x | 15.9 x |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | 1.39 x | 0.65 x | 1.38 x | 0.99 x | 0.85 x | 0.8 x | 0.77 x |
| EV / Revenue | 1.39 x | 0.65 x | 1.38 x | 0.99 x | 0.85 x | 0.8 x | 0.77 x |
| EV / EBITDA | 8.54 x | 10.4 x | 8.45 x | 6.09 x | 5.76 x | 5.99 x | 5.13 x |
| EV / FCF | 20.8 x | -46.8 x | 14.5 x | -194 x | - | 26.4 x | 8.6 x |
| FCF Yield | 4.81% | -2.14% | 6.88% | -0.52% | - | 3.78% | 11.6% |
| Price to Book | 2.43 x | 1.06 x | - | - | - | - | - |
| Nbr of stocks (in thousands) | 38,341 | 39,057 | 39,434 | 39,940 | 40,388 | 40,619 | - |
| Reference price 2 | 28.28 | 12.34 | 28.57 | 21.37 | 18.79 | 16.79 | 16.79 |
| Announcement Date | 11/12/19 | 11/17/20 | 11/16/21 | 11/15/22 | 11/14/23 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 780.6 | 738.3 | 818.1 | 859.4 | 893.4 | 853 | 888.4 |
| EBITDA 1 | 126.9 | 46.4 | 133.3 | 140.1 | 131.8 | 113.9 | 133 |
| EBIT 1 | 87.7 | 24.2 | 102.8 | 111.5 | 99.4 | 76.85 | 95.15 |
| Operating Margin | 11.23% | 3.28% | 12.57% | 12.97% | 11.13% | 9.01% | 10.71% |
| Earnings before Tax (EBT) 1 | 22.6 | -71.8 | 28.6 | 44.5 | 31.3 | 47.33 | 70.3 |
| Net income 1 | 16.6 | -57.1 | 17.4 | 30.3 | 48.2 | 35.42 | 51.72 |
| Net margin | 2.13% | -7.73% | 2.13% | 3.53% | 5.4% | 4.15% | 5.82% |
| EPS 2 | 0.4300 | -1.470 | 0.4300 | 0.7300 | 1.080 | 0.7725 | 1.055 |
| Free Cash Flow 1 | 52.1 | -10.3 | 77.5 | -4.4 | - | 25.8 | 79.3 |
| FCF margin | 6.67% | -1.4% | 9.47% | -0.51% | - | 3.02% | 8.93% |
| FCF Conversion (EBITDA) | 41.06% | - | 58.14% | - | - | 22.65% | 59.6% |
| FCF Conversion (Net income) | 313.86% | - | 445.4% | - | - | 72.83% | 153.31% |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 11/12/19 | 11/17/20 | 11/16/21 | 11/15/22 | 11/14/23 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: September | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 226.3 | 198.8 | 214.7 | 214.5 | 231.4 | 205.6 | 228.2 | 232.2 | 227.4 | 190 | 205.2 | 224.5 | 233.3 | 194.3 | 213.2 |
| EBITDA 1 | 39.9 | - | - | 36 | 35.9 | 25.4 | 30.2 | 37.7 | 38.5 | 19 | 25.85 | 32.3 | 37.2 | - | - |
| EBIT 1 | 32.6 | 22.7 | 31.5 | 28.2 | 29.1 | 17.7 | 23 | 29.1 | 29.6 | 9.8 | 16.75 | 22.8 | 27.5 | - | - |
| Operating Margin | 14.41% | 11.42% | 14.67% | 13.15% | 12.58% | 8.61% | 10.08% | 12.53% | 13.02% | 5.16% | 8.16% | 10.16% | 11.79% | - | - |
| Earnings before Tax (EBT) 1 | 14.8 | 3.3 | 13.6 | 13.5 | 14.1 | 5.4 | 7.8 | 17.1 | 1 | -0.6 | 10.43 | 15.67 | 20.63 | 7.15 | 14.1 |
| Net income 1 | 8.7 | 1.4 | 7.6 | 8.2 | 13.1 | 3.1 | 4.1 | 9.1 | 31.9 | -0.5 | 7.625 | 11.92 | 15.65 | 5.45 | 10.75 |
| Net margin | 3.84% | 0.7% | 3.54% | 3.82% | 5.66% | 1.51% | 1.8% | 3.92% | 14.03% | -0.26% | 3.72% | 5.31% | 6.71% | 2.8% | 5.04% |
| EPS 2 | 0.2000 | 0.0300 | 0.1800 | 0.2000 | 0.3200 | 0.0800 | 0.1000 | 0.2100 | 0.6600 | -0.0100 | 0.1600 | 0.2725 | 0.3400 | 0.1200 | 0.2300 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/16/21 | 2/8/22 | 5/3/22 | 8/2/22 | 11/15/22 | 1/31/23 | 5/2/23 | 8/1/23 | 11/14/23 | 2/6/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt | 365 | 355 | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 2.878 x | 7.644 x | - | - | - | - | - |
| Free Cash Flow 1 | 52.1 | -10.3 | 77.5 | -4.4 | - | 25.8 | 79.3 |
| ROE (net income / shareholders' equity) | 11.5% | 0.6% | 3.5% | 5.96% | 8.75% | 6.9% | 7.6% |
| ROA (Net income/ Total Assets) | 4.95% | 0.3% | 1.52% | 2.6% | 3.96% | 5.2% | 7.3% |
| Assets 1 | 335.4 | -19,033 | 1,144 | 1,166 | 1,217 | 681.2 | 708.6 |
| Book Value Per Share | 11.60 | 11.60 | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - |
| Capex 1 | 19.8 | 23.5 | 15.1 | 21.3 | - | 31.4 | 21 |
| Capex / Sales | 2.54% | 3.18% | 1.85% | 2.48% | - | 3.68% | 2.36% |
| Announcement Date | 11/12/19 | 11/17/20 | 11/16/21 | 11/15/22 | 11/14/23 | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
16.79
USD
Average target price
27.88
USD
Spread / Average Target
+66.02%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -18.10% | 682M | |
| -12.91% | 19.08B | |
| -46.21% | 2.65B | |
| +18.15% | 1.87B | |
| -3.12% | 1.61B | |
| +23.78% | 1.21B | |
| -10.69% | 1.02B | |
| -20.89% | 905M | |
| -7.14% | 716M | |
| -.--% | 301M |
- Stock Market
- Equities
- VREX Stock
- Financials Varex Imaging Corporation
